Rexahn Pharmaceuticals (RNN) Submits Phase IIb Protocol to FDA for Major Depressive Disorder Treatment
Rexahn Pharmaceuticals Inc., a clinical stage company focused on developing and commercializing oncology and CNS therapeutics, has submitted a phase…